There’s been a lot of blogging about vaccines lately:
Mark Meier at Science Progress explains how a cocaine-addiction vaccine was developed, and what questions and hurdles it still faces.
Emily Monosson at The Neighborhood Toxicologist investigates EPA’s decisions about nanotechnology regulation.
David Roberts at Gristmill looks at the big stories emerging from the League of Conservation Voters’ just-released scorecard.
Roy M. Poses MD at Health Care Renewal delves into the torturous supply chain and inadequate oversight of Baxter’s heparin.
Maggie Mahar at Health Beat wonders where the doctors were during the “Cholesterol Con” that’s now coming to light.
Merrill Goozner at GoozNews suggests a different approach that FDA could use regarding the approval of Avastin for breast cancer.
Lisa Codipoti at Womenstake uses a personal example to illustrate one of the problems with primary care in our current system.
Michael Kremer at Global Health Policy explains why mass treatment through schools is an effective use of the funds President Bush has pledged to invest in fighting neglected tropical diseases.